Farmer's lung disease

Summary

Farmer’s lung disease (MONDO:0001971) is a disease. A subtype of hypersensitivity pneumonitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	farmer’s lung disease
Mondo ID	MONDO:0001971
Orphanet	99906
DOID	DOID:14453
ICD-10-CM	J67.0
ICD-11	666590509
NCIT	C34605
SNOMED CT	18690003
UMLS	C0015634
MedGen	8785
GARD	0006427
MedDRA	10016221
Is cancer (heuristic)	no

Also known as: farmer lung · farmer’s lung

Disease family

This is a subtype of hypersensitivity pneumonitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › allergic respiratory disease › hypersensitivity pneumonitis › farmer’s lung disease

Related subtypes (13): ventilation pneumonitis, bagassosis, malt worker’s lung, cork-handlers’ disease, maple bark strippers’ lung, bird fancier’s lung, mushroom workers’ lung, sick building syndrome, hypersensitivity pneumonitis, familial, idiopathic chronic eosinophilic pneumonia, house allergic alveolitis, non-fibrotic hypersensitivity pneumonitis, fibrotic hypersensitivity pneumonitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.